| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK | /s/ Adam C. Vandervoort | 03 Dec 2025 | 0001375088 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDOC | Common Stock | Options Exercise | +1,505 | +2% | 76,684 | 01 Dec 2025 | Direct | F1 | ||
| transaction | TDOC | Common Stock | Options Exercise | +4,418 | +5.8% | 81,102 | 01 Dec 2025 | Direct | F2 | ||
| transaction | TDOC | Common Stock | Options Exercise | +5,350 | +6.6% | 86,452 | 01 Dec 2025 | Direct | F2 | ||
| transaction | TDOC | Common Stock | Sale | $42,831 | -5,720 | -6.6% | $7.49 | 80,732 | 02 Dec 2025 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDOC | Performance Stock Units | Options Exercise | $0 | -1,505 | -50% | $0.000000 | 1,510 | 01 Dec 2025 | Common Stock | 1,505 | Direct | F1, F4 | |
| transaction | TDOC | Restricted Stock Units | Options Exercise | $0 | -4,418 | -50% | $0.000000 | 4,418 | 01 Dec 2025 | Common Stock | 4,418 | Direct | F2, F5 | |
| transaction | TDOC | Restricted Stock Units | Options Exercise | $0 | -5,350 | -17% | $0.000000 | 26,750 | 01 Dec 2025 | Common Stock | 5,350 | Direct | F6, F7 |
| Id | Content |
|---|---|
| F1 | Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| F2 | Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| F3 | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| F4 | The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| F5 | On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| F6 | Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. |
| F7 | One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |